Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini

Details for Australian Patent Application No. 2004270741 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Wyrzykiewicz, Tradeusz Krzysztof; Swayze, Eric E.; Migawa, Michael T.

Agent Pizzeys

Pub. Number AU-B-2004270741

PCT Pub. Number WO2005/023825

Priority 60/501,719 09.09.03 US; 60/568,039 03.05.04 US; 10/872,106 18.06.04 US; 60/568,489 06.05.04 US

Filing date 9 September 2004

Wipo publication date 17 March 2005

Acceptance publication date 24 February 2011

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

30 March 2006 PCT application entered the National Phase

  PCT publication WO2005/023825 Priority application(s): WO2005/023825

24 February 2011 Application Accepted

  Published as AU-B-2004270741

23 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004270743-Head restraint device with back member

2004270740-4 - heterobicyclyamino - substituted quinazolines and analogues therof as capsaicin - antagonists